Preferential Selection of Low-Frequency, Lipopolysaccharide-Modified, Colistin-Resistant Mutants with a Combination of Antimicrobials in Acinetobacter baumannii.
Humans
Colistin
/ pharmacology
Acinetobacter baumannii
/ genetics
Lipopolysaccharides
Acinetobacter Infections
/ drug therapy
Meropenem
/ pharmacology
Microbial Sensitivity Tests
Carbapenems
/ therapeutic use
Anti-Bacterial Agents
/ pharmacology
Ciprofloxacin
/ pharmacology
Disinfectants
/ pharmacology
Drug Resistance, Multiple, Bacterial
/ genetics
Acinetobacter baumannii
LPS
colistin
lpxACD
meropenem
pmrAB
Journal
Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614
Informations de publication
Date de publication:
26 10 2022
26 10 2022
Historique:
pubmed:
30
9
2022
medline:
29
10
2022
entrez:
29
9
2022
Statut:
ppublish
Résumé
Colistin, which targets lipopolysaccharide (LPS), is used as a last-resort drug against severe infections caused by drug-resistant Acinetobacter baumannii. However, A. baumannii possesses two colistin-resistance mechanisms. LPS modification caused by mutations in
Identifiants
pubmed: 36173297
doi: 10.1128/spectrum.01928-22
pmc: PMC9602988
doi:
Substances chimiques
Colistin
Z67X93HJG1
Lipopolysaccharides
0
Meropenem
FV9J3JU8B1
Carbapenems
0
Anti-Bacterial Agents
0
Ciprofloxacin
5E8K9I0O4U
Disinfectants
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0192822Références
Clin Infect Dis. 2006 Mar 1;42(5):692-9
pubmed: 16447117
Clin Infect Dis. 2019 Aug 16;69(5):769-776
pubmed: 30462182
Can J Infect Dis Med Microbiol. 2017;2017:1839190
pubmed: 29181039
Lancet Infect Dis. 2018 Apr;18(4):391-400
pubmed: 29456043
Antimicrob Agents Chemother. 2011 Jul;55(7):3370-9
pubmed: 21576434
Front Microbiol. 2014 Nov 26;5:643
pubmed: 25505462
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Antimicrob Agents Chemother. 2014 May;58(5):2972-5
pubmed: 24566189
Microb Drug Resist. 2020 May;26(5):429-433
pubmed: 31657659
Microb Genom. 2019 Oct;5(10):
pubmed: 31599224
J Antimicrob Chemother. 2010 Feb;65(2):233-8
pubmed: 19996144
mBio. 2019 Jul 16;10(4):
pubmed: 31311879
Diagn Microbiol Infect Dis. 2009 May;64(1):43-51
pubmed: 19362258
Antibiotics (Basel). 2020 Mar 12;9(3):
pubmed: 32178356
Front Med (Lausanne). 2021 Aug 12;8:677720
pubmed: 34476235
Front Cell Infect Microbiol. 2017 Mar 13;7:55
pubmed: 28348979
Infection. 2020 Dec;48(6):835-851
pubmed: 32875545
Antimicrob Agents Chemother. 2011 Aug;55(8):3743-51
pubmed: 21646482
Front Cell Infect Microbiol. 2021 Feb 26;11:633817
pubmed: 33718283
Virulence. 2018 Dec 31;9(1):930-942
pubmed: 29638177
Clin Microbiol Rev. 2008 Jul;21(3):538-82
pubmed: 18625687
J Infect Dis. 2013 Oct 1;208(7):1142-51
pubmed: 23812239
Antimicrob Agents Chemother. 2008 Jan;52(1):333-6
pubmed: 17967915
Emerg Microbes Infect. 2020 Dec;9(1):868-885
pubmed: 32284036
Int J Antimicrob Agents. 2017 May;49(5):526-535
pubmed: 28163137
J Clin Microbiol. 2012 Nov;50(11):3609-13
pubmed: 22933604
Eur J Clin Microbiol Infect Dis. 2018 Jun;37(6):1009-1019
pubmed: 29524060
Front Microbiol. 2016 Nov 01;7:1715
pubmed: 27847502
Eur J Clin Microbiol Infect Dis. 2018 Mar;37(3):443-454
pubmed: 29353377
Microb Pathog. 2020 Feb;139:103887
pubmed: 31765766
Antimicrob Agents Chemother. 2011 Jun;55(6):3022-4
pubmed: 21402838
PLoS Comput Biol. 2017 Jun 8;13(6):e1005595
pubmed: 28594827
Pathog Dis. 2014 Aug;71(3):292-301
pubmed: 24376225
mBio. 2021 Dec 21;12(6):e0309921
pubmed: 34844428
Antimicrob Agents Chemother. 2010 Dec;54(12):4971-7
pubmed: 20855724
Sci Rep. 2017 Oct 27;7(1):14216
pubmed: 29079752
J Chemother. 2021 Feb;33(1):1-11
pubmed: 32677578
J Antimicrob Chemother. 2018 Nov 1;73(11):2952-2959
pubmed: 30124845
J Antimicrob Chemother. 2010 Dec;65(12):2598-601
pubmed: 20861141
Antimicrob Agents Chemother. 2007 Oct;51(10):3471-84
pubmed: 17646423
Antimicrob Agents Chemother. 2019 Feb 26;63(3):
pubmed: 30617096
J Antimicrob Chemother. 2012 Jul;67(7):1607-15
pubmed: 22441575
Nat Rev Microbiol. 2018 Feb;16(2):91-102
pubmed: 29249812
Nucleic Acids Res. 2018 Jul 6;46(12):6152-6165
pubmed: 29878158
J Hosp Infect. 2020 Nov;106(3):447-453
pubmed: 32927013
Front Microbiol. 2020 Apr 17;11:573
pubmed: 32373082
J Antimicrob Chemother. 2020 Feb 1;75(2):271-282
pubmed: 31586417
Antimicrob Agents Chemother. 2018 Dec 21;63(1):
pubmed: 30323035
Antibiotics (Basel). 2021 Nov 03;10(11):
pubmed: 34827282
Front Cell Infect Microbiol. 2017 May 24;7:209
pubmed: 28596943
Clin Microbiol Infect. 2019 Sep;25(9):1156.e1-1156.e7
pubmed: 30790686
Clin Infect Dis. 2015 May 1;60(9):1295-303
pubmed: 25632010
Infect Immun. 2005 Nov;73(11):7569-77
pubmed: 16239560
BMC Infect Dis. 2015 Dec 09;15:559
pubmed: 26653099
Nature. 1998 Apr 2;392(6675):449-50
pubmed: 9548250
Infection. 2022 Jun;50(3):569-581
pubmed: 34982411
Mol Microbiol. 2018 Jan;107(1):47-56
pubmed: 29114953
J Antimicrob Chemother. 2015 Nov;70(11):2981-6
pubmed: 26311838
Antibiotics (Basel). 2021 Oct 16;10(10):
pubmed: 34680840
Science. 1996 Nov 8;274(5289):980-2
pubmed: 8875939
Bioinformatics. 2014 Jul 15;30(14):2068-9
pubmed: 24642063
Antibiotics (Basel). 2021 Jul 20;10(7):
pubmed: 34356801
Curr Med Res Opin. 2015 Apr;31(4):707-21
pubmed: 25697677
BMC Res Notes. 2021 Mar 4;14(1):83
pubmed: 33663564
Front Microbiol. 2018 Feb 12;9:153
pubmed: 29483899
Int J Antimicrob Agents. 2020 Mar;55(3):105862
pubmed: 31837449
Nature. 1987 Sep 10-16;329(6135):162-4
pubmed: 3041230